Medtronic's wholly-owned subsidiary Physio-Control and BeneChill have signed a strategic partnership to launch the RhinoChill IntraNasal Cooling System in Europe.
RhinoChill is a non-invasive, portable system for transnasally cooling the head and lowering the body’s core temperature immediately following cardiac arrest, stroke or traumatic brain injury.
Initially, the partnership will focus on bringing the RhinoChill System to market in the UK, Germany, Austria, Switzerland, Belgium, Netherlands and Luxemburg during the first quarter of 2011, utilizing Physio-Control’s extensive European distribution network.
Additionally, as part of the strategic alliance, the two companies will work jointly to develop additional applications for BeneChill and work towards making the RhinoChill System available in the US.
BeneChill CEO Alan Raffensperger said BeneChill is proud to announce our partnership with Physio-Control – a provider of external defibrillation and monitoring technology.
"The strategic partnership with Physio-Control will ensure that our breakthrough RhinoChill cooling technology will be available for emergency and critical care health care professionals in the UK, The Netherlands, Belgium, Luxemburg, Austria and Switzerland," Raffensperger said.